Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma

NCT00489944 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Intraocular Melanoma

Interventions

DRUG: cisplatin
DRUG: sunitinib malate
DRUG: tamoxifen citrate
PROCEDURE: adjuvant therapy

Sponsor

San Diego Pacific Oncology & Hematology Associates